127 related articles for article (PubMed ID: 467961)
21. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
22. Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.
Kutz K; Schulte A; Just C; Lindstaedt H; Reiter B
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):171-7. PubMed ID: 503248
[No Abstract] [Full Text] [Related]
23. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes.
Homcy CJ; Margolis S
Atherosclerosis; 1974; 19(3):381-91. PubMed ID: 4828566
[No Abstract] [Full Text] [Related]
25. Treatment of hyperlipoproteinemia type II with etofibrate.
Gustafson A
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):498-502. PubMed ID: 528096
[TBL] [Abstract][Full Text] [Related]
26. Correlating metabolism of plasma and tissue cholesterol with that of plasma-lipoproteins.
Sodhi HS; Kudchodkar BJ
Lancet; 1973 Mar; 1(7802):513-9. PubMed ID: 4119950
[No Abstract] [Full Text] [Related]
27. [Preliminary study of the effects of nicotinic-N-oxide acid causing hypolipidemia administered alone or in combination with clofibrate].
Palamara G; De Luca G; Materazzi M
Boll Chim Farm; 1977 Oct; 116(10):596-600. PubMed ID: 607948
[No Abstract] [Full Text] [Related]
28. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
Brattsand R
Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
[No Abstract] [Full Text] [Related]
29. [Further comment on the lipotropic action of niacin].
Vinogradov VV; Mandrik KA; Larin FS; Buko VU; Pavlenia AK
Vopr Pitan; 1979; (2):34-40. PubMed ID: 86235
[TBL] [Abstract][Full Text] [Related]
30. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
31. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
Vessby B; Lithell H; Gustafsson IB; Boberg J
Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377
[TBL] [Abstract][Full Text] [Related]
32. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
[No Abstract] [Full Text] [Related]
33. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Kaffarnik H; Schneider J; Haase W
Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
[TBL] [Abstract][Full Text] [Related]
34. Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism.
Frantz ID
Adv Exp Med Biol; 1977; 82():649-55. PubMed ID: 920422
[No Abstract] [Full Text] [Related]
35. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
Sterner W; Schultz A
Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
[No Abstract] [Full Text] [Related]
36. Effect of clofibrate on the metabolism of oleate in the perfused rat liver.
Ide T; Sugano M
Biochem Pharmacol; 1983 Sep; 32(17):2583-8. PubMed ID: 6615553
[TBL] [Abstract][Full Text] [Related]
37. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
Mishkel MA; Webb WF
Biochem Pharmacol; 1967 May; 16(5):897-905. PubMed ID: 6036737
[No Abstract] [Full Text] [Related]
38. [The effect of orotic and nicotinic acids on the incorporation of 1-C14-acetate into the total lipids and cholesterol of rat liver].
Chagovets RV; Shushevich SI; Khalmuradov AG
Vopr Pitan; 1966; 25(2):24-9. PubMed ID: 5998316
[No Abstract] [Full Text] [Related]
39. Clofibrate and nicotinic acid.
Hoffer A
Can Med Assoc J; 1972 Sep; 107(6):488 passim. PubMed ID: 5057001
[No Abstract] [Full Text] [Related]
40. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
Stevens TJ; Stafford WW; Day CE; Block EM
Artery; 1983; 12(2):81-94. PubMed ID: 6678582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
